Acuta Capital Partners as of June 30, 2026
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 23 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 19.3 | $28M | 83k | 334.79 | |
| Aadi Bioscience (WHWK) | 15.0 | $22M | 4.7M | 4.58 | |
| Tango Therapeutics (TNGX) | 8.5 | $12M | 391k | 31.26 | |
| Sutro Biopharma (STRO) | 6.3 | $9.0M | 270k | 33.20 | |
| Arrivent Biopharma (AVBP) | 5.3 | $7.6M | 219k | 34.74 | |
| 4d Molecular Therapeutics In (FDMT) | 4.7 | $6.8M | 508k | 13.30 | |
| Bright Minds Biosciences Com New (DRUG) | 4.5 | $6.5M | 93k | 70.20 | |
| Ocular Therapeutix (OCUL) | 3.6 | $5.2M | 533k | 9.82 | |
| Erasca (ERAS) | 3.4 | $4.9M | 265k | 18.32 | |
| Surrozen Com New (SRZN) | 3.1 | $4.5M | 173k | 25.95 | |
| Argen Se - Sponsored Adr (ARGX) | 3.0 | $4.4M | 4.7k | 927.77 | |
| Moonlake Immunotherapeutics Class Ord A (MLTX) | 2.9 | $4.2M | 216k | 19.47 | |
| Design Therapeutics (DSGN) | 2.8 | $4.1M | 283k | 14.47 | |
| Minerva Neurosciences Com New (NERV) | 2.7 | $3.9M | 710k | 5.55 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.7 | $3.8M | 562k | 6.81 | |
| Avalyn Pharma Com Shs | 2.6 | $3.8M | 115k | 32.92 | |
| Avalo Therapeutics Com New (AVTX) | 2.4 | $3.4M | 186k | 18.48 | |
| Amylyx Pharmaceuticals (AMLX) | 2.1 | $3.0M | 168k | 17.96 | |
| Artiva Biotherapeutics (ARTV) | 1.8 | $2.5M | 260k | 9.70 | |
| Compass Therapeutics (CMPX) | 0.9 | $1.3M | 595k | 2.19 | |
| United Therapeutics Corporation (UTHR) | 0.8 | $1.2M | 2.2k | 541.83 | |
| Contineum Therapeutics Inc-a Cl A (CTNM) | 0.7 | $1.0M | 63k | 16.39 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.7 | $939k | 29k | 32.45 |
